FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
We have now added a new section called the "Assay History List" to the "At A Gla...